These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 34266934)
1. Final Long-Term Reporting from a Randomized Controlled IDE Trial for Lumbar Artificial Discs in Single-Level Degenerative Disc Disease: 7-Year Results. Radcliff K; Zigler J; Braxton E; Buttermann G; Coric D; Derman P; Garcia R; Jorgensen A; Ferko NC; Situ A; Yue J Int J Spine Surg; 2021 Aug; 15(4):612-632. PubMed ID: 34266934 [TBL] [Abstract][Full Text] [Related]
2. Five-year Results of a Randomized Controlled Trial for Lumbar Artificial Discs in Single-level Degenerative Disc Disease. Yue JJ; Garcia R; Blumenthal S; Coric D; Patel VV; Dinh DH; Buttermann GR; Deutsch H; Miller LE; Persaud EJ; Ferko NC Spine (Phila Pa 1976); 2019 Dec; 44(24):1685-1696. PubMed ID: 31404055 [TBL] [Abstract][Full Text] [Related]
3. Lumbar Total Disc Replacement for Discogenic Low Back Pain: Two-year Outcomes of the activL Multicenter Randomized Controlled IDE Clinical Trial. Garcia R; Yue JJ; Blumenthal S; Coric D; Patel VV; Leary SP; Dinh DH; Buttermann GR; Deutsch H; Girardi F; Billys J; Miller LE Spine (Phila Pa 1976); 2015 Dec; 40(24):1873-81. PubMed ID: 26630435 [TBL] [Abstract][Full Text] [Related]
4. Predictors of long-term clinical outcomes in adult patients after lumbar total disc replacement: development and validation of a prediction model. Coric D; Zigler J; Derman P; Braxton E; Situ A; Patel L J Neurosurg Spine; 2022 Mar; 36(3):399-407. PubMed ID: 34624839 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Aesculap Implant Systems activl Artificial Disc for the treatment of degenerative disc disease. Shein D; Shue J; Girardi F Expert Rev Med Devices; 2016 Dec; 13(12):1069-1072. PubMed ID: 27807981 [TBL] [Abstract][Full Text] [Related]
6. The activL(®) Artificial Disc: a next-generation motion-preserving implant for chronic lumbar discogenic pain. Yue JJ; Garcia R; Miller LE Med Devices (Auckl); 2016; 9():75-84. PubMed ID: 27274317 [TBL] [Abstract][Full Text] [Related]
7. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Zigler J; Delamarter R; Spivak JM; Linovitz RJ; Danielson GO; Haider TT; Cammisa F; Zuchermann J; Balderston R; Kitchel S; Foley K; Watkins R; Bradford D; Yue J; Yuan H; Herkowitz H; Geiger D; Bendo J; Peppers T; Sachs B; Girardi F; Kropf M; Goldstein J Spine (Phila Pa 1976); 2007 May; 32(11):1155-62; discussion 1163. PubMed ID: 17495770 [TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up. Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066 [TBL] [Abstract][Full Text] [Related]
9. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease. Murrey D; Janssen M; Delamarter R; Goldstein J; Zigler J; Tay B; Darden B Spine J; 2009 Apr; 9(4):275-86. PubMed ID: 18774751 [TBL] [Abstract][Full Text] [Related]
10. ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study. Janssen ME; Zigler JE; Spivak JM; Delamarter RB; Darden BV; Kopjar B J Bone Joint Surg Am; 2015 Nov; 97(21):1738-47. PubMed ID: 26537161 [TBL] [Abstract][Full Text] [Related]
11. Motion preservation following total lumbar disc replacement at the lumbosacral junction: a prospective long-term clinical and radiographic investigation. Wuertinger C; Annes RDÀ; Hitzl W; Siepe CJ Spine J; 2018 Jan; 18(1):72-80. PubMed ID: 28673830 [TBL] [Abstract][Full Text] [Related]
12. A comparison of patients who have undergone 1-Level versus 2-Level ProDisc arthroplasty: a prospective study with minimum of 5-year follow-up. Yue J; Zhang K; Bai HX; Du J; Cammisa F; Abjornson C; Mo F Spine (Phila Pa 1976); 2013 Jun; 38(14):1194-8. PubMed ID: 23392415 [TBL] [Abstract][Full Text] [Related]
13. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months. Delamarter R; Zigler JE; Balderston RA; Cammisa FP; Goldstein JA; Spivak JM J Bone Joint Surg Am; 2011 Apr; 93(8):705-15. PubMed ID: 21398574 [TBL] [Abstract][Full Text] [Related]
14. Mid- to long-term results of total lumbar disc replacement: a prospective analysis with 5- to 10-year follow-up. Siepe CJ; Heider F; Wiechert K; Hitzl W; Ishak B; Mayer MH Spine J; 2014 Aug; 14(8):1417-31. PubMed ID: 24448028 [TBL] [Abstract][Full Text] [Related]
15. ProDisc-C versus anterior cervical discectomy and fusion for the surgical treatment of symptomatic cervical disc disease: two-year outcomes of Asian prospective randomized controlled multicentre study. Kumar N; Liu ZJ; Poon WS; Park CK; Lin RM; Cho KS; Niu CC; Chen HY; Madhu S; Shen L; Sun Y; Mak WK; Lin CL; Lee SB; Park CK; Lee DC; Tung FI; Wong HK Eur Spine J; 2022 May; 31(5):1260-1272. PubMed ID: 35325298 [TBL] [Abstract][Full Text] [Related]
16. Lumbar total disc arthroplasty in patients older than 60 years of age: a prospective study of the ProDisc prosthesis with 2-year minimum follow-up period. Bertagnoli R; Yue JJ; Nanieva R; Fenk-Mayer A; Husted DS; Shah RV; Emerson JW J Neurosurg Spine; 2006 Feb; 4(2):85-90. PubMed ID: 16506473 [TBL] [Abstract][Full Text] [Related]
17. ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study. Zigler JE; Delamarter R; Murrey D; Spivak J; Janssen M Spine (Phila Pa 1976); 2013 Feb; 38(3):203-9. PubMed ID: 23080427 [TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part II: evaluation of radiographic outcomes and correlation of surgical technique accuracy with clinical outcomes. McAfee PC; Cunningham B; Holsapple G; Adams K; Blumenthal S; Guyer RD; Dmietriev A; Maxwell JH; Regan JJ; Isaza J Spine (Phila Pa 1976); 2005 Jul; 30(14):1576-83; discussion E388-90. PubMed ID: 16025025 [TBL] [Abstract][Full Text] [Related]
19. Prospective, multicenter clinical trial comparing M6-C compressible six degrees of freedom cervical disc with anterior cervical discectomy and fusion for the treatment of single-level degenerative cervical radiculopathy: 2-year results of an FDA investigational device exemption study. Phillips FM; Coric D; Sasso R; Lanman T; Lavelle W; Blumenthal S; Lauryssen C; Guyer R; Albert T; Zigler J; Cammisa F; Milam RA Spine J; 2021 Feb; 21(2):239-252. PubMed ID: 33096243 [TBL] [Abstract][Full Text] [Related]
20. Two- to 3-Year Follow-Up of ProDisc-L: Results From a Prospective Randomized Trial of Arthroplasty Versus Fusion. Zigler JE; Sachs BL; Rashbaum RF; Ohnmeiss DD SAS J; 2007; 1(2):63-7. PubMed ID: 25802580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]